Skip to main content
Top
Published in: Rheumatology International 5/2006

01-03-2006 | Original Article

HgCl2 challenge in Brown Norway rats lead to dermatitis instead of arthritis

Authors: K. Schümann, A. Lebeau, T. Ettle, O. Adam

Published in: Rheumatology International | Issue 5/2006

Login to get access

Abstract

A wide range of methods are described to produce adjuvant arthritis in rats by antigen exposure. Studies using these methods are rarely controlled histologically though the result can be paw dermatitis instead of arthritis. Three male Brown Norway rats were injected s.c. with HgCl2 (1 mg Hg/kg body weight) on five alternating days following closely a well described scheme for induction of adjuvant arthritis. Extent of paw oedema was assessed sonographically. Location and extent of inflammatory responses were inspected histologically. Swollen reddish and painful paw oedema started to develop on day 13 increasing until day 16. Oedema increased skin-to-bone and skin-to-skin distance across the inflamed paws significantly. Histological examination on day 16 revealed marked dermatitis with dense cellular infiltrates, single cell necrosis and fibrin exudation. In contrast, no inflammatory responses were observed in the joints. Use of a well described scheme for induction of adjuvant arthritis produced dermatitis of the paw with identical time course, clinical and sonographic appearance as expected for arthritis. This observation strongly suggests the need to check the histology on location and the kind of inflammatory response when a model for adjuvant arthritis is altered or used for the first time.
Literature
1.
go back to reference Tedesco LS, Fuseler J, Grisham M, Wolf R, Roerig SC (2002) Therapeutic administration of nitric oxide synthase inhibitors reverses hyperalgesia but not inflammation in a rat model of polyarthritis. Pain 95:215–223PubMedCrossRef Tedesco LS, Fuseler J, Grisham M, Wolf R, Roerig SC (2002) Therapeutic administration of nitric oxide synthase inhibitors reverses hyperalgesia but not inflammation in a rat model of polyarthritis. Pain 95:215–223PubMedCrossRef
2.
go back to reference Kang SS, Pak SC, Choi SH (2002) The effect of whole bee venom on arthritis. Am J Chin Med 30:73–80PubMedCrossRef Kang SS, Pak SC, Choi SH (2002) The effect of whole bee venom on arthritis. Am J Chin Med 30:73–80PubMedCrossRef
3.
go back to reference D’Souza M, DeSouza P (1998) Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats. Drug Dev Ind Pharm 24:841–52PubMedCrossRef D’Souza M, DeSouza P (1998) Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats. Drug Dev Ind Pharm 24:841–52PubMedCrossRef
4.
go back to reference Ballet S, Mauborgne A, Benoliel JJ, Bourgoin S, Hamon M, Cesselin F, Collin E (1998) Polyarthritis-associated changes in the opioid control of spinal CGPR release in the rat. Brain Res 796:198–208PubMedCrossRef Ballet S, Mauborgne A, Benoliel JJ, Bourgoin S, Hamon M, Cesselin F, Collin E (1998) Polyarthritis-associated changes in the opioid control of spinal CGPR release in the rat. Brain Res 796:198–208PubMedCrossRef
6.
go back to reference Kiely PD, Thiru S, Oliveira DBG (1995) Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest 73:284–293PubMed Kiely PD, Thiru S, Oliveira DBG (1995) Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest 73:284–293PubMed
7.
go back to reference Bolon B, Campagnuolo G, Feige U (2002) Duration of bone protection by a single osteoprotegrin injection in rats with adjuvant-induced arthritis. Cell Mol Life Sci 59:1569–1576PubMedCrossRef Bolon B, Campagnuolo G, Feige U (2002) Duration of bone protection by a single osteoprotegrin injection in rats with adjuvant-induced arthritis. Cell Mol Life Sci 59:1569–1576PubMedCrossRef
8.
go back to reference Brühl H, Cihak J, Schneider MA, Plachý J, Rupp T, Wenzel I, Shakarami M, Milz S, Ellwart JW, Stangassinger M, Schlöndorff D, Mack M (2004) Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J Immunol 172:890–898PubMed Brühl H, Cihak J, Schneider MA, Plachý J, Rupp T, Wenzel I, Shakarami M, Milz S, Ellwart JW, Stangassinger M, Schlöndorff D, Mack M (2004) Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J Immunol 172:890–898PubMed
9.
go back to reference Weinberger A, Halpern M, Zahalka MA, Quintana F, Traub L, Moroz C (2003) Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis. Arthritis Rheum 48:846–853PubMedCrossRef Weinberger A, Halpern M, Zahalka MA, Quintana F, Traub L, Moroz C (2003) Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis. Arthritis Rheum 48:846–853PubMedCrossRef
10.
go back to reference Wilder RL, Calandra GB, Garvin J, Wright KD, Hansen CT (1982) Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 25:1064–1072PubMedCrossRef Wilder RL, Calandra GB, Garvin J, Wright KD, Hansen CT (1982) Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 25:1064–1072PubMedCrossRef
11.
go back to reference Wooley PH, Luthra HS, Stuart JM, David CS (1981) Type II collagen-induced arthritis in mice. Major histocompatibility complex (I region) linkage and antibody correlated. J Exp Med 154:688–700PubMedCrossRef Wooley PH, Luthra HS, Stuart JM, David CS (1981) Type II collagen-induced arthritis in mice. Major histocompatibility complex (I region) linkage and antibody correlated. J Exp Med 154:688–700PubMedCrossRef
12.
go back to reference Karalis K, Crofford L, Wilder RL, Chrousos GP (1995) Glucocorticoid and/or glucocorticoid antagonis affects in inflammatory disease-susceptible Lewis rats and inflammatory disease resistant Fisher rats. Endocrinology 136:3107–12PubMedCrossRef Karalis K, Crofford L, Wilder RL, Chrousos GP (1995) Glucocorticoid and/or glucocorticoid antagonis affects in inflammatory disease-susceptible Lewis rats and inflammatory disease resistant Fisher rats. Endocrinology 136:3107–12PubMedCrossRef
13.
go back to reference Jansson AM, Lorentzen JC, Bucht A (2000) CD8+ cells suppress oil-induced arthritis. Clin Exp Immunol 120:532–6PubMedCrossRef Jansson AM, Lorentzen JC, Bucht A (2000) CD8+ cells suppress oil-induced arthritis. Clin Exp Immunol 120:532–6PubMedCrossRef
Metadata
Title
HgCl2 challenge in Brown Norway rats lead to dermatitis instead of arthritis
Authors
K. Schümann
A. Lebeau
T. Ettle
O. Adam
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0002-6

Other articles of this Issue 5/2006

Rheumatology International 5/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.